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We have entered an era of lung cancer screening, to the extent that low-dose CT scans for lung cancer screening are being offered for free at some institutions (http://www.
lahey.org/lungscreening/). Although free may be a very good price, it may come at sub-
stantial cost. These costs include a wide range of detected abnormalities, many of which 
have uncertain clinical significance and can create considerable anxiety in patients and 
their health care providers. One of these abnormalities is the ground glass nodule (GGN), 
a focal CT finding where there is increased attenuation through which normal parenchymal 
and airway structures remain visible. In the current issue of the journal, Kobayyashi et al.1 
describe their experience in observing GGNs. Their aim was to describe the natural his-
tory of a most unnatural phenomenon, a radiographic finding in asymptomatic individuals. 
They followed 108 lesions in 61 individuals detected at screening or as incidental findings. 
Most of the findings remained stable with observation up to 12 years. Twenty-seven percent 
increased in size, with some showing both growth and increases in a solid component. In 
their analysis, all lesions demonstrating growth did so within the first 3 years. Primarily on 
the basis of growth, 21 patients went on to surgical resection with almost half the lesions 
being atypical adenomatous hyperplasia or adenocarcinoma-in-situ, with most of the 
remaining lesions being minimally invasive adenocarcinoma. They correctly conclude and 
suggest that GGNs should be observed for at least 3 years before deciding that they will 
remain stable. Before incorporating this into practice, there is still much to consider. For 
example, the context is very important. The population Kobayyashi studied is a uniquely 
Japanese population. Two-thirds of the subjects were nonsmoking women, and 90% of the 
adenocarcinomas contained epidermal growth factor receptor mutations. Although indolent 
growth may be a nearly universal characteristic of GGNs, the “natural” history needs to be 
defined in other populations as well.
This study does not answer some of the most important questions surrounding 
GGNs. With wide spread CT screening for lung cancer, GGNs will become more frequent, 
and the goals of management will become more complex. Minimizing procedures, 
radiation exposure, and expenditures will become increasingly important. An emphasis 
on outcomes, with less focus on specific histology and when and how to intervene will 
be needed. Kobayyashi et al. had universally good outcomes, but with significant costs, 
including 12 pulmonary resections for premalignant lesions (adenomatous hyperplasia 
and adenocarcinoma-in-situ). Given the very indolent nature of all of these abnormalities, 
some of the malignant lesions might be candidates for “overdiagnosis” of lung cancer. 
To this end, several organizations have considered the GGN and developed guidelines 
and recommendations. This includes the National Comprehensive Cancer Network, the 
American Association for Thoracic Surgery, and most recently the Fleischner Society.2 Of 
these, the Fleischner Society recommendations are the most complete and complex.
In 2005, the Fleischner Society published their ubiquitous guidelines for small pul-
monary nodules incidentally detected on CT scan.3 These recommendations are simple, 
clear, and easily condensed into the small table that is posted next to radiology workstations 
around the world. However, in 2005, they only dealt with solid nodules. Now the Fleischner 
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Society has moved on to subsolid pulmonary nodules, and 
things get much more complex. GGNs are more heteroge-
neous, in their radiographic appearance, behavior, and histol-
ogy. As expected, the new guidelines are much more complex 
than those for solid nodules and unlikely to be condensed into 
a single, simple table. All the recommendations made are well 
researched and justified by current literature and available data, 
but still represent the opinions of experts in the field. They have 
yet to be tested prospectively and have not been applied in the 
real world. Research has shown that even the simple guidelines 
for solid nodules can be difficult to follow.4 This fact may rep-
resent one of the issues the Fleischner GGN recommendations 
will have to face in the real world: Are physicians willing and 
able to follow a complex nodule follow-up pathway, and are 
the descriptors (size, density, cystic component, etc.) distinct 
enough to be applicable in daily practice? The current data are 
robust for pure GGNs between 5 and 8 mm and justify a more 
conservative approach for this subtype. It gets more compli-
cated once mixed solid and GGNs are to be assessed. The clear 
distinction between solid and ground glass as well as  the size 
and proportion of each component determines outcome and 
follow-up recommendations. Interpretative consistency will be 
very important in such cases.
There are technical issues raised by the Fleischner 
Society GGN recommendations. The Fleischner society rec-
ommends contiguous 1-mm thick slices for assessment of 
GGNs, something not addressed in other guidelines. There 
are potential pitfalls with respect to differences in reconstruc-
tion algorithms, which may alter the appearance and hence 
density of a GGNs and the challenges of comparing scans 
from two different institutions and/or manufacturers should 
not be overlooked.
These recent recommendations from the Fleischner 
society on the management of GGNs provide a solid founda-
tion and starting point for further investigation. They touch 
on many areas of uncertainty and acknowledge the limita-
tions of many of our standard procedures, such as positron 
emission tomography scans and biopsies, and they place an 
emphasis on minimizing radiation exposure and procedures. 
Their approach is supported by the new data from Kobayyashi 
et al. in this issue of the journal. It is hoped that these rec-
ommendations will guide practitioners and more importantly 
serve as the foundation for outcome-oriented investigation in 
the management of these increasingly ubiquitous radiographic 
findings.
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